- Release Date: 13/02/12 18:02
- Summary: ALLOT: CRP: Share Purchase Plan Allotment
- Price Sensitive: No
- Download Document 1.4KB
CRP 13/02/2012 16:02 ALLOT REL: 1602 HRS Chatham Rock Phosphate Limited ALLOT: CRP: Share Purchase Plan Allotment 13 February 2012 Chatham Rock Phosphate Raises $325,000 under Share Purchase Plan The Chatham Rock Phosphate share purchase plan closed on 3 February 2012. Under the Plan, 72 eligible shareholders have subscribed for 1,624,492 shares in total raising approximately $325,000 at the issue price of $0.20 per share. The Board is very pleased with this outcome given the timing of this offer and thanks shareholders for their continued support of the company. In addition to the allotment of shares under the share purchase plan, Chatham Rock Phosphate has also undertaken placements today of 986,110 shares to qualified investors at an issue price of $0.20 per share. Full particulars of these allotments are set out below. On behalf of the Board, Chris Castle Managing Director Email: [email protected] Class of security: Ordinary Shares ISIN: NZWENE0003S0 Number issued: 2,610,602 Issue price: $0.20 per share Payment in cash: Yes Fully paid: Yes Percentage of class: 5.16% Purpose of the issue: Funds raised will be applied as announced to the market on 1 December 2011. Authority for the issue: Board resolutions Date of issue: 13 February 2012 Total number of securities on issue following allotments: 53,217,538 ordinary shares End CA:00219464 For:CRP Type:ALLOT Time:2012-02-13 16:02:07
- Forums
- NZX - By Stock
- Ann: ALLOT: CRP: Share Purchase Plan Allotment
CRP
chatham rock phosphate limited
Add to My Watchlist
0.00%
!
9.3¢

Ann: ALLOT: CRP: Share Purchase Plan Allotment
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
The Watchlist
PSC
PROSPECT RESOURCES LIMITED
Sam Hosack, MD & CEO
Sam Hosack
MD & CEO
SPONSORED BY The Market Online